Masaaki Nakashima

Efficacy of ensitrelvir against SARS-CoV-2 in a delayed-treatment mouse model

M. Torii, Haruaki Nobori, T. Sanaki, 2022, The Journal of antimicrobial chemotherapy.

Oral 3CL protease inhibitor ensitrelvir suppressed SARS-CoV-2 shedding and infection in a hamster aerosol transmission model.

Haruaki Nobori, Teruhisa Kato, K. Fukao, 2024, Antiviral research.